Teva starts "thorough" review as chief departs

13 February 2017 - Deborah Wilkes

Archived

Teva said in-market sales by PGT Healthcare – its OTC joint venture with Procter & Gamble – increased by 18% to USD530 million in the fourth quarter of 2016. Teva is seeking a new chief executive officer following the sudden departure of Erez Vigodman, and has started a "thorough" review of its business.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: